CD8A and non-small cell lung carcinoma: The combination of Shenyi capsule and chemotherapy [76] can increase the proportion of NK+, CD3+, and CD4+ cells to a greater extent and reduce the percentage of CD8+ cells, in order to regulate the immune function of NSCLC via bidirectional adjustment in terms of CD8+/CD4+.